A Study of Pregnenolone in the Treatment of Individuals With Autism

Completed · Phase 2

Conditions studied: Autistic Disorder

In brief

This study will assess the tolerability and effectiveness of pregnenolone in the treatment of behavioral deficits in adults with autism. Pregnenolone is a naturally occurring hormone found in the body which has been shown to help with the function of nerve cells. It is also shown to modulate the activity of certain brain receptors implicated in autism. We hope to examine the tolerability of pregnenolone in adults with autism.

Key facts

Study ID
NCT01881737
Run by
Stanford University
People needed
15
Starts
2011-07-01
Expected to finish
2013-09-01
Last updated by the study team
2017-03-29

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.